http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107737129-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-529 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107737129-B |
| titleOfInvention | Tetradoxin new application |
| abstract | The purposes in drug for losing neuropathic pain after preparation treatment RTX induction bleb the invention discloses tetradoxin.Tetradoxin oral preparation of the present invention is that tetradoxin is instant or the oral preparations such as enteric-coated micro-pill, instant or enteric microplate.The oral preparation loses neuropathic pain sample symptom after can significantly improve resin toxin (Resiniferatoxin, RTX) induction bleb, and the analgesic effect of oral preparation is better than drug administration by injection mode.Tetradoxin oral preparation clinical use safety, compliance is good, can be used as the medicinal usage of something lost neuropathic pain after treatment bleb. |
| priorityDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.